Literature DB >> 22186766

Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.

Qiong Yu1, Xueyuan Zhang, Changyou Ji, Hua Yang, Minghua Gao, Suling Hong, Guohua Hu.   

Abstract

This study aimed at investigating the survival rate and prognostic factors of laryngeal carcinoma patients in the absence of the use of laryngectomy, radiotherapy, and chemotherapy. A total of 167 cases of laryngeal carcinoma without the use of laryngectomy, radiotherapy, or chemotherapy were analyzed retrospectively. Surveyed items included age, smoking history, tumor family history, tuberculosis history, primary site, pathological grade, T-stage, N-stage, clinical stage, and whether tracheotomy had been performed. Survival rates were calculated using the Kaplan-Meier method. For univariate analysis, comparison among/between groups was performed using the log-rank test. Multivariate analysis was carried out using the Cox proportional hazard model. Overall median survival time was 16 ± 1.44 months, and overall 1- and 2-year survival rates were 56.4 and 26.5%, respectively. No patient survived over 5 years in cases diagnosed for more than 5 years (except for cases that were lost). The median survival time of clinical stage 0/I/II was 28 ± 3.81 months, and 1- and 2-year survival rates were 79.3 and 59.3%, respectively; the median survival time of III/IV clinical stages was 11 ± 1.32 months, and 1- and 2-year survival rates were 45.5 and 10.6%, respectively. Univariate analysis showed that primary site, pathological grade, T-stage, N-stage, and clinical stage were significant prognostic factors for the survival of the patients (P < 0.05). Whether tracheotomy had been performed was not significant for affecting survival rates. Multivariate analysis showed survival rates were statistically correlated with T-stage and N-stage (P < 0.05). The development of laryngeal carcinoma course was faster, without treatment to the tumor itself, even if palliative surgery such as tracheostomy would not improve the survival rate. In laryngeal carcinoma patients with no surgery, radiotherapy or chemotherapy, the factors affecting the survival rates include primary site, pathological grade, T-stage, N-stage, and clinical stage, and of them, T-stage and N-stage are the independent prognostic factors.

Entities:  

Mesh:

Year:  2011        PMID: 22186766     DOI: 10.1007/s00405-011-1873-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Prognostic factors in squamous cell carcinoma of the larynx.

Authors:  D Danic; M Maruĭć; B Uzarević; D Milicić
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2000 May-Jun       Impact factor: 1.538

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  Reexamining the treatment of advanced laryngeal cancer.

Authors:  Kerry D Olsen
Journal:  Head Neck       Date:  2010-01       Impact factor: 3.147

Review 4.  The management of early laryngeal cancer: options for patients and therapists.

Authors:  Gary Back; Sanjai Sood
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-04       Impact factor: 2.064

5.  Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.

Authors:  Hedda Haugen; Karl-Axel Johansson; Claes Mercke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

6.  Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.

Authors:  Jing Jin; Zhongxing Liao; Li Gao; Xiaodong Huang; Guozhen Xu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

7.  Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma.

Authors:  Theodoros A Papadas; Evangelos C Alexopoulos; Antony Mallis; Eleni Jelastopulu; Nicholas S Mastronikolis; Panos Goumas
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-18       Impact factor: 2.503

8.  Management of stage IV glottic carcinoma: therapeutic outcomes.

Authors:  Gershon J Spector; Donald G Sessions; Jason Lenox; Donald Newland; Joseph Simpson; Bruce H Haughey
Journal:  Laryngoscope       Date:  2004-08       Impact factor: 3.325

9.  Histopathological study of correlation between laryngeal space invasion and lymph node metastasis in glottic carcinoma.

Authors:  H Chijiwa; K Sato; H Umeno; T Nakashima
Journal:  J Laryngol Otol Suppl       Date:  2009

10.  Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.

Authors:  F Christopher Holsinger; Heather Y Lin; Vincent Bassot; Ollivier Laccourreye
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

View more
  5 in total

1.  Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.

Authors:  Tianyi Wu; Lingmei Qu; Guoqing He; Linli Tian; Liang Li; Han Zhou; Qian Jin; Jingyuan Ren; Yu Wang; Jingting Wang; Xuan Kan; Ming Liu; Jia Shen; Mian Guo; Yanan Sun
Journal:  Oncotarget       Date:  2016-03-08

2.  Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study.

Authors:  Nima Daneshi; Mohammad Fararouei; Mohammad Mohammadianpanah; Mohammad Zare-Bandamiri; Somayeh Parvin; Mostafa Dianatinasab
Journal:  J Cancer Epidemiol       Date:  2018-06-03

3.  Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.

Authors:  Haozhan Yuan; Hong Jiang; Yanting Wang; Yameng Dong
Journal:  Biosci Rep       Date:  2019-06-18       Impact factor: 3.840

4.  PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma.

Authors:  Nan Wang; Honghong Yan; Di Wu; Zheng Zhao; Xiaoqi Chen; Qian Long; Changlin Zhang; Xiaohao Wang; Wuguo Deng; Xuekui Liu
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

5.  Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance.

Authors:  Janusz Klatka; Ewelina Grywalska; Maria Klatka; Magdalena Wasiak; Adrian Andrzejczak; Jacek Rolinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.